SEEK
LIVE

Serial Number

79100334

Owner

PepTcell Limited

Filing Date

Mar 21, 2011

Add to watchlist:

No watchlists yet
View on USPTO

SEEK Trademark

Serial Number: 79100334 • Registration: 4107395

SEEK is a trademark filed by PepTcell Limited on March 21, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

PepTcell Limited (3 trademarks)

100 Fetter Lane
London EC4A 1BN , GB

Entity Type: 99

Trademark Details

Filing Date

March 21, 2011

Registration Date

March 6, 2012

Published for Opposition

December 20, 2011

Cancellation Date

March 22, 2021

Goods & Services

Pharmaceutical preparations for use in the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses; veterinary preparations, namely, amino acids for veterinary purposes, anti-infective products for veterinary use, bacterial preparations for veterinary purposes, biochemical preparations for use in the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses, blood substitute for veterinary use, veterinary vaccines, pain relief medication for veterinary use, veterinary preparations for the treatment of intestinal bacteria, veterinary parasiticides for livestock use; sanitary sterilizing preparations; dietetic substances, namely, foods adapted for medical use; medical plasters, disinfectants for medical instruments and sanitary purposes, fungicides, herbicides, preparations for destroying vermin, pain relief medications; nutritional substances, namely, nutritional substances in the nature of capsules containing glucosamine and chondroitin and nutritional supplements, vitamins, mineral supplements, and nutritional supplements, namely, glucosamine and chondroitin; nutraceuticals for use as a dietary supplement, nutritional substances, namely, intravenous fluids used for nutrition; food supplements for medical purposes, dietetic beverages and dietetic foods adapted for medical use; medical use and nutritional supplements, vitamins, mineral supplements, bacteriological preparations for medical or veterinary purposes; biological preparations for the treatment of influenza, HIV, hepatitis C, hepatitis B, mosquito borne diseases, tuberculosis, rheumatoid arthritis, rotavirus, blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory disorders, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and disorders, sexual dysfunction, urological disorders, viral, protozoa and bacterial disorders, diseases and illnesses, diagnostic preparations for medical purposes, chemicals for use in the manufacture of pharmaceuticals; vaccines

Licensing of intellectual property; licensing of technologies in relation to medical and scientific research; regulatory compliance consulting in the field of pharmaceuticals and pharmaceutical compounds; official regulatory assistance and advice in the fields of chemical, sanitary, food, beverage, nutritional, naturopathic, pharmaceutical, medical, veterinary and healthcare products and services

Medical services, veterinary services, hygienic care for human beings; medical clinics, convalescent home services, dentistry, healthcare services, nursing homes, midwife services, opticians services, physiotherapy services, psychology services, blood bank services, agricultural services, namely, agricultural advice, spreading of fertilizers and other agricultural chemicals; horticultural services; forestry services, namely, providing advice pertaining to pest control for forestry; hospice, hospital, medical assistance, nursing services, pharmaceutical advice, and rest home services; surgery, assistance and advice in the fields of sanitary, nutritional, naturopathic, allopathic, pharmaceutical, medical and healthcare products and services; information and advisory services relating to the foregoing; including the provision of such services via the Internet, by online means and/or by communications networks, provision of information relating to pharmaceuticals, drug delivery systems, vaccines

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Oct 10, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 10, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 30, 2019 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 29, 2019 INTS
INVALIDATION PROCESSED
Jun 29, 2019 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 12, 2019 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 14, 2019 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 21, 2019 NREP
CANCELLED SECTION 71
Oct 12, 2018 C71T
NOTIFICATION PROCESSED BY IB
Oct 25, 2012 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 4, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 13, 2012 FICS
FINAL DISPOSITION PROCESSED
Jul 13, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 6, 2012 R.PR
PUBLISHED FOR OPPOSITION
Dec 20, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 30, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 30, 2011 OP2R
NOTICE OF PUBLICATION
Nov 30, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 15, 2011 PREV
ASSIGNED TO LIE
Nov 15, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 25, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 21, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 21, 2011 TROA
NON-FINAL ACTION MAILED
Oct 17, 2011 CNRT
NON-FINAL ACTION WRITTEN
Oct 17, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2011 TROA
REFUSAL PROCESSED BY IB
Sep 11, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 24, 2011 RFCS
REFUSAL PROCESSED BY MPU
Aug 24, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 24, 2011 RFCR
NON-FINAL ACTION WRITTEN
Aug 23, 2011 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 16, 2011 MAFR
ASSIGNED TO EXAMINER
Aug 12, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 11, 2011 REPR